Genetic variants in the CD2AP locus are associated with increased CSF tau levels in mild cognitive impairment, decreased cognitive function in middle-aged individuals with a family history of AD, and increased risk of AD, all-cause dementia, and vascular dementia [74–76]. The gene discussed is MAPT; the disease is Cognitive impairment.